News
-
World Federation of Chinese Medicine Societies Attends the 158th Session of the WHO Executive Board
The 158th session of the World Health Organization's Executive Board （158th EB）was held from February 2 to 7 at WHO headquarters in Geneva, Switzerland. The meeting emphasized the importance of both national health sovereignty and global collaboration, adopted multiple resolutions, and laid the groundwork for the 79th World Health Assembly. At the invitation of WHO, the World Federation of Chinese Medicine Societies (WFCMS) sent a delegation composed of Vice President Anton Staudinger, Executive Board Member Christina Staudinger, and accompanying delegate Marco Schrötter.Mar 11,2026 -
WHO Consultant on Health Systems Resilience & Essential Public Health Functions Visits WFCMS
On the afternoon of March 2, Ms. Redda Seifeldin, Consultant for Health Systems Resilience and Essential Public Health Functions at the World Health Organization (WHO) Headquarters, visited the World Federation of Chinese Medicine Societies (WFCMS). She held a meeting with Dr. Wang Jing, Assistant to the Secretary-General of WFCMS, for in-depth discussions on strengthening health systems resilience and integrating Traditional Chinese Medicine (TCM) into public health systems.Mar 4,2026 -
Successful Conference in Tianjin for ICH Working Committee Transition and Seminar on the Protection, Inheritance, and Innovative Development of TCM
On January 31, 2026, the Transition Conference of the Working Committee of Traditional Chinese Medicine Intangible Cultural Heritage of WFCMS and the Seminar on the Protection, Inheritance, and Innovative Development of Traditional Medicine ICH was successfully held in Tianjin, China.Feb 4,2026 -
Special Session on Overseas Promotion of Chinese Time-Honored Brands (Guangzhou Pharmaceutical Holdings Limited Session) Successfully Held at the 22nd World Congress of Chinese Medicine Sub-Forum
On the morning of October 31st local time, Special Session on Overseas Promotion of Chinese Time-Honored Brands (Guangzhou Pharmaceutical Group Session), themed Innovative Development of Chinese Medicine Time-Honored Brands and Research on the Internationalization Strategy of Guangzhou Pharmaceutical Holdings Limited", was successfully held at the Sydney International Convention Centre as part of the 22nd World Congress of Chinese Medicine.Dec 4,2025 -
The 22nd WCCM Sub-Venue-2025 China Time-honored TCM Development Conference cum Global Dialogue on the Safeguarding and Sharing of TCM’s Intangible Cultural Heritage Successfully Concludes in Sydney
From October 30th to November 1st, 2025, the 22nd World Congress of Chinese Medicine was grandly held at the International Convention Centre Sydney in Australia. Held concurrently as a specialized parallel session, the 2025 China Time-honored TCM Development Conference cum Global Dialogue on the Safeguarding and Sharing of TCM’s Intangible Cultural Heritage took place. As a key event under the Ministry of Commerce's "Time-Honored Brands Carnival," the conference centered on the theme "Enduring Brands, Continuation of Civilization."Dec 4,2025 -
The Fourth Plenary Session of the Fifth Council Board, Executive Council, and Supervisory Board of the World Federation of Chinese Medicine Societies Convenes Successfully
On November 1, 2025, the Fourth Plenary Session of the Fifth Council Board, Executive Council, and Supervisory Board of the World Federation of Chinese Medicine Societies (WFCMS) was successfully held in Sydney, Australia. Members of the Council Board and Supervisory Board from 24 countries and regions worldwide, including Australia, Brazil, Canada, China, Fiji, France, Germany, Hong Kong China, Japan, Macao China, Malaysia, New Zealand, the Philippines, Portugal, Russia, Singapore, South Africa, South Korea, Spain, Taiwan China, Thailand, the United Kingdom, the United States, and Vietnam, attended the meeting.Dec 4,2025
